US drug industry middlemen defend business model amid accusations of raising patient costs By Reuters
By Amina Niasse and Bhanvi Satija (Reuters) -U.S. pharmaceutical industry middlemen defended their role in the healthcare system during a...
By Amina Niasse and Bhanvi Satija (Reuters) -U.S. pharmaceutical industry middlemen defended their role in the healthcare system during a...
By Suzanne McGee and Hannah Lang (Reuters) -The U.S. Securities and Exchange Commission has given preliminary approval to at least...
(Reuters) -Power provider Southern Company (NYSE:) CEO Chris Womack said on Monday he expects more industry commitments to build gigawatt-scale...
Wednesday morning, I saw a tweet from the Longform podcast: Jay Caspian Kang, a staff writer at The New Yorker,...